Kwality Pharmaceuticals Ltd.
Snapshot View

349.95 +3.40 ▲1.0%

03 February 2023, 04:01:00 PM
Volume: 4,076

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.kwalitypharma.com
Market Cap 361.92 Cr.
Enterprise Value(EV) 430.03 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 115.64 Trailing Twelve Months Ending 2022-03
Price-Earning Ratio (PE) 3.03 Trailing Twelve Months Ending 2022-03
Industry PE 32.22 Trailing Twelve Months Ending 2022-03
Book Value / Share 192.66 Trailing Twelve Months Ending 2022-03
Price to Book Value 1.82 Calculated using Price: 349.95
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 1.04 Cr. 10,376,198 Shares
FaceValue 10
Company Profile
The company ‘Kwality Pharmaceuticals Limited' was incorporated on May 04, 1983 vide Certificate of Incorporation issued by the Registrar of Companies, Punjab, H.P. and Chandigarh. It is engaged in the business of manufacturing of broad range of finished pharmaceutical formulations in a dosage form. It carries out its production through state-of-the-art manufacturing units situated at 6th Mile Stone, Village Nag Kalan, Majitha Road, Amritsar - 143006, Punjab, which is also its registered/administrative office and another manufacturing facility situated at 1-A Industrial Area, Raja ka bagh, Jassur, Himachal Pradesh. Both of its manufacturing facilities are well equipped and multiple products are manufactured at these facilities. Since incorporation, the company is ever progressing in Domestic and International market based on its commitment towards high quality and timely supplies. It provides specified and quality products for its customers while maintaining honesty, integrity and loyalty to its employees and customers.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+0.98%
1 Week
+1.48%
1 Month
-5.78%
3 Month
+2.82%
6 Month
+15.94%
1 Year
-37.73%
2 Year
+513.95%
5 Year
+484.22%
10 Year
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 5.26 4.43 6.54 14.41 16.51 23.13 20.10 28.21 99.66
Return on Capital Employed (%) 10.52 9.58 12.34 19.64 19.19 21.91 18.49 26.36 98.00
Return on Assets (%) 2.66 2.21 2.90 5.37 5.29 7.50 6.90 9.97 47.33

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 18 19 22 26 30 37 46 61 181 201
Non Curr. Liab. 2 1 3 4 5 8 20 28 31 26
Curr. Liab. 15 17 27 42 62 61 68 78 130 114
Minority Int. 0 0 0 -1 -1 -1 -1 -1 -1 -1
Equity & Liab. 35 37 51 71 96 105 132 166 341 339
Non Curr. Assets 13 13 13 18 21 30 43 60 113 128
Curr. Assets 22 24 38 53 75 75 89 106 228 210
Misc. Exp. not W/O 0 0 0 0
Total Assets 35 37 51 71 96 105 132 166 341 339

Profit Loss View Details >>

Particulars 9 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Net Sales 60 52 74 98 137 166 139 262 456
Other Income 0 0 0 1 1 1 4 2 4
Total Income 60 53 75 100 138 167 143 264 460
Total Expenditure -56 -49 -69 -89 -126 -151 -125 -233 -284
PBIDT 4 4 5 10 12 16 18 30 175
Interest -1 -1 -1 -2 -2 -2 -3 -3 -3
Depreciation -1 -1 -2 -3 -3 -3 -4 -6 -11
Taxation -1 -1 -1 -2 -3 -3 -3 -6 -42
Exceptional Items
PAT 1 1 1 3 4 8 8 15 120
Minority Interest 0 0 0 0 0 0 0 0
Share Associate
Other Related Items
Consolidated Net Profit 1 1 2 3 5 8 8 15 120
Adjusted EPS 1 1 2 3 4 7 8 15 116

Cash Flow View Details >>

Particulars 9 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. -1 1 -3 4 -1 14 6 27 64
Cash Fr. Inv. -3 -1 -2 -7 -6 -12 -18 -23 -63
Cash Fr. Finan. 3 1 6 5 5 -2 12 1 6
Net Change -1 1 0 2 -1 0 0 4 7
Cash & Cash Eqvt 1 1 1 3 2 1 2 6 13

Shareholding Pattern View Details >>

9 Qtrs 2020-03 (%) 2020-09 (%) 2021-03 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 51.52 51.52 54.13 54.24 54.24 54.43 54.45 54.45 54.45
Public 48.48 48.48 45.87 45.76 45.76 45.57 45.55 45.55 45.55
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Sat, 21 Jan 2023
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for AKNM Suppliers Pvt Ltd
Sat, 21 Jan 2023
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for AKNM Suppliers Pvt Ltd
Tue, 10 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
With reference to captioned subject please find enclosed herewith confirmation certificate issued in accordance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended December 31 2022 as received from Bigshare Services Private Limited the Registrar and Share Transfer Agent of the Company.

Technical Scans View Details >>

Fri, 03 Feb 2023
High Delivery Percentage High Delivery Percentage
Opening at High Opening at High
High Decrease in 1 Month High Decrease in 1 Month
High Decrease in 1 Year High Decrease in 1 Year
High Increase in 2 Years High Increase in 2 Years

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 246,567.66 1,027.65 +2.0%
Cipla Ltd. 82,812.97 1,026.00 +0.1%
Divi's Laboratories Ltd. 76,573.08 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. 72,577.66 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. 61,039.46 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. 52,289.82 1,545.00 +0.3%
Abbott India Ltd. 44,198.55 20,800.00 +1.5%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 58.54 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-12 31.39 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 25.59 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 19.92 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.70 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.92 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-09 50.12 20,800.00 +1.5%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.46 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-12 3.65 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 6.31 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.30 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.20 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.20 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-09 16.28 20,800.00 +1.5%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-03 0.04 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-03 0.00 20,800.00 +1.5%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-03 29.95 20,800.00 +1.5%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-03 29.95 20,800.00 +1.5%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-03 4,919.27 20,800.00 +1.5%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-03 798.70 20,800.00 +1.5%

FAQ's On Kwality Pharmaceuticals Ltd.

What is Kwality Pharma share price?

Can I buy Kwality Pharma shares now?

What is the Market Cap of Kwality Pharma?

What are the key metrics to analyse Kwality Pharma?

What is the 52 Week High and Low of Kwality Pharma?

What is the trend of Kwality Pharma share price?